This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations
Notes
Also issued in print: 2023
Bibliography
Includes bibliographical references
Audience
Specialized
Notes
Description based on online resource; title from PDF title page (viewed on January 30, 2023)